1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Hip Reconstruction - Pipeline Review, 2015

Hip Reconstruction - Pipeline Review, 2015

  • September 2015
  • -
  • Global Data
  • -
  • 156 pages

Hip Reconstruction - Pipeline Review, 2015

Summary

GlobalData's Medical Devices sector report, “Hip Reconstruction - Pipeline Review, 2015" provides an overview of Hip Reconstruction devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hip Reconstruction pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Hip Reconstruction devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Hip Reconstruction devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Hip Reconstruction devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table Of Contents

Hip Reconstruction - Pipeline Review, 2015
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 7
2 Introduction 8
2.1 Hip Reconstruction Overview 8
3 Products under Development 10
3.1 Hip Reconstruction - Pipeline Products by Stage of Development 10
3.2 Hip Reconstruction - Pipeline Products by Segment 11
3.3 Hip Reconstruction - Pipeline Products by Territory 12
3.4 Hip Reconstruction - Pipeline Products by Regulatory Path 13
3.5 Hip Reconstruction - Pipeline Products by Estimated Approval Date 14
3.6 Hip Reconstruction - Ongoing Clinical Trials 15
4 Hip Reconstruction - Pipeline Products under Development by Companies 16
4.1 Hip Reconstruction Companies - Pipeline Products by Stage of Development 16
4.2 Hip Reconstruction - Pipeline Products by Stage of Development 18
5 Hip Reconstruction Companies and Product Overview 20
5.1 Amedica Corporation Company Overview 20
5.1.1 Amedica Corporation Pipeline Products and Ongoing Clinical Trials Overview 20
5.2 Bonovo Orthopedics, Inc. Company Overview 22
5.2.1 Bonovo Orthopedics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 22
5.3 Corentec Co., Ltd. Company Overview 24
5.3.1 Corentec Co., Ltd. Pipeline Products and Ongoing Clinical Trials Overview 24
5.4 Corin Group Plc Company Overview 25
5.4.1 Corin Group Plc Pipeline Products and Ongoing Clinical Trials Overview 25
5.5 DePuy Companies Company Overview 26
5.5.1 DePuy Companies Pipeline Products and Ongoing Clinical Trials Overview 26
5.6 Dimicron Inc. Company Overview 34
5.6.1 Dimicron Inc. Pipeline Products and Ongoing Clinical Trials Overview 34
5.7 Exactech, Inc. Company Overview 35
5.7.1 Exactech, Inc. Pipeline Products and Ongoing Clinical Trials Overview 35
5.8 Fortis Orthopedics Company Overview 42
5.8.1 Fortis Orthopedics Pipeline Products and Ongoing Clinical Trials Overview 42
5.9 Fraunhofer Institute for Applied Polymer Research Company Overview 43
5.9.1 Fraunhofer Institute for Applied Polymer Research Pipeline Products and Ongoing Clinical Trials Overview 43
5.10 Implants International Limited Company Overview 45
5.10.1 Implants International Limited Pipeline Products and Ongoing Clinical Trials Overview 45
5.11 INOR Orthopaedics Company Overview 46
5.11.1 INOR Orthopaedics Pipeline Products and Ongoing Clinical Trials Overview 46
5.12 JRI Orthopaedics Ltd Company Overview 48
5.12.1 JRI Orthopaedics Ltd Pipeline Products and Ongoing Clinical Trials Overview 48
5.13 KYOCERA Medical Corporation Company Overview 49
5.13.1 KYOCERA Medical Corporation Pipeline Products and Ongoing Clinical Trials Overview 49
5.14 Limacorporate S.p.a. Company Overview 51
5.14.1 Limacorporate S.p.a. Pipeline Products and Ongoing Clinical Trials Overview 51
5.15 MX Orthopedics, Corp. Company Overview 54
5.15.1 MX Orthopedics, Corp. Pipeline Products and Ongoing Clinical Trials Overview 54
5.16 Nano Interface Technology, Inc. Company Overview 55
5.16.1 Nano Interface Technology, Inc. Pipeline Products and Ongoing Clinical Trials Overview 55
5.17 Naviswiss AG Company Overview 56
5.17.1 Naviswiss AG Pipeline Products and Ongoing Clinical Trials Overview 56
5.18 OrthoGrid Systems Company Overview 57
5.18.1 OrthoGrid Systems Pipeline Products and Ongoing Clinical Trials Overview 57
5.19 OrthoPediatrics Corp. Company Overview 58
5.19.1 OrthoPediatrics Corp. Pipeline Products and Ongoing Clinical Trials Overview 58
5.20 PLD Corporation Limited (Inactive) Company Overview 59
5.20.1 PLD Corporation Limited (Inactive) Pipeline Products and Ongoing Clinical Trials Overview 59
5.21 PreSRV Ltd. Company Overview 60
5.21.1 PreSRV Ltd. Pipeline Products and Ongoing Clinical Trials Overview 60
5.22 Renova Orthopedics, LLC Company Overview 61
5.22.1 Renova Orthopedics, LLC Pipeline Products and Ongoing Clinical Trials Overview 61
5.23 SAS HyPrevention Company Overview 62
5.23.1 SAS HyPrevention Pipeline Products and Ongoing Clinical Trials Overview 62
5.24 SINTEF Company Overview 63
5.24.1 SINTEF Pipeline Products and Ongoing Clinical Trials Overview 63
5.25 Stryker Corporation Company Overview 64
5.25.1 Stryker Corporation Pipeline Products and Ongoing Clinical Trials Overview 64
5.26 Tech Manage Corp. Company Overview 66
5.26.1 Tech Manage Corp. Pipeline Products and Ongoing Clinical Trials Overview 66
5.27 University of Alberta Company Overview 67
5.27.1 University of Alberta Pipeline Products and Ongoing Clinical Trials Overview 67
5.28 University of South Florida Company Overview 68
5.28.1 University of South Florida Pipeline Products and Ongoing Clinical Trials Overview 68
5.29 University of Warwick Company Overview 70
5.29.1 University of Warwick Pipeline Products and Ongoing Clinical Trials Overview 70
5.30 Zimmer Biomet Holdings, Inc. Company Overview 72
5.30.1 Zimmer Biomet Holdings, Inc. Pipeline Products and Ongoing Clinical Trials Overview 72
6 Hip Reconstruction- Recent Developments 80
7 Appendix 153
7.1 Methodology 153
7.2 About GlobalData 155
7.3 Contact Us 156
7.4 Disclaimer 156

1.1 List of Tables
Table 1: Hip Reconstruction - Pipeline Products by Stage of Development 10
Table 2: Hip Reconstruction - Pipeline Products by Segment 11
Table 3: Hip Reconstruction - Pipeline Products by Territory 12
Table 4: Hip Reconstruction - Pipeline Products by Regulatory Path 13
Table 5: Hip Reconstruction - Pipeline Products by Estimated Approval Date 14
Table 6: Hip Reconstruction - Ongoing Clinical Trials 15
Table 7: Hip Reconstruction Companies - Pipeline Products by Stage of Development 16
Table 8: Hip Reconstruction - Pipeline Products by Stage of Development 18
Table 9: Amedica Corporation Pipeline Products and Ongoing Clinical Trials Overview 20
Table 10: Infinia Total Hip Implant II - Product Status 21
Table 11: Infinia Total Hip Implant II - Product Description 21
Table 12: Bonovo Orthopedics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 22
Table 13: JMM Total Hip System - Product Status 22
Table 14: JMM Total Hip System - Product Description 22
Table 15: Konknow Hip System - Product Status 23
Table 16: Konknow Hip System - Product Description 23
Table 17: Corentec Co., Ltd. Pipeline Products and Ongoing Clinical Trials Overview 24
Table 18: Bencox ID Cemented Stem - Collarless - Product Status 24
Table 19: Bencox ID Cemented Stem - Collarless - Product Description 24
Table 20: Corin Group Plc Pipeline Products and Ongoing Clinical Trials Overview 25
Table 21: Alpha-fit Total Hip System - Product Status 25
Table 22: Alpha-fit Total Hip System - Product Description 25
Table 23: DePuy Companies Pipeline Products and Ongoing Clinical Trials Overview 26
Table 24: Bone Preserving Hip Stem - Product Status 27
Table 25: Bone Preserving Hip Stem - Product Description 27
Table 26: DeltaMotion Hip System - Product Status 28
Table 27: DeltaMotion Hip System - Product Description 28
Table 28: Hip Resurfacing System - Product Status 29
Table 29: Hip Resurfacing System - Product Description 29
Table 30: New Poly Hip Bearing - Product Status 30
Table 31: New Poly Hip Bearing - Product Description 30
Table 32: Next Generation Hip System - Product Status 31
Table 33: Next Generation Hip System - Product Description 31
Table 34: DePuy Companies - Ongoing Clinical Trials Overview 32
Table 35: DeltaMotion Hip System - A Multi-center, Prospective, Uncontrolled Post Market Clinical Follow-up Study (PMCFS) to Monitor the Survival and Performance of the DeltaMotion Cup System in Subjects Requiring a Total Hip Replacement 33
Table 36: DeltaMotion Hip System - Prospective Study Deltamotion - DAA THA Study 33
Table 37: Dimicron Inc. Pipeline Products and Ongoing Clinical Trials Overview 34
Table 38: Triadyme-C - Product Status 34
Table 39: Triadyme-C - Product Description 34
Table 40: Exactech, Inc. Pipeline Products and Ongoing Clinical Trials Overview 35
Table 41: Alteon Acetabular System - Product Status 36
Table 42: Alteon Acetabular System - Product Description 36
Table 43: Alteon HA System - Product Status 37
Table 44: Alteon HA System - Product Description 37
Table 45: Alteon Revision Modular System - Product Status 38
Table 46: Alteon Revision Modular System - Product Description 38
Table 47: Exactech GPS Hip System - Product Status 39
Table 48: Exactech GPS Hip System - Product Description 39
Table 49: Hip Revision System - Product Status 40
Table 50: Hip Revision System - Product Description 40
Table 51: HIP Wedge Stem - Product Status 41
Table 52: HIP Wedge Stem - Product Description 41
Table 53: Fortis Orthopedics Pipeline Products and Ongoing Clinical Trials Overview 42
Table 54: MiHip System - Product Status 42
Table 55: MiHip System - Product Description 42
Table 56: Fraunhofer Institute for Applied Polymer Research Pipeline Products and Ongoing Clinical Trials Overview 43
Table 57: Enhanced Durability Resurfacing Endoprosthesis - Product Status 44
Table 58: Enhanced Durability Resurfacing Endoprosthesis - Product Description 44
Table 59: Implants International Limited Pipeline Products and Ongoing Clinical Trials Overview 45
Table 60: Phoenix Re-Surf - Product Status 45
Table 61: Phoenix Re-Surf - Product Description 45
Table 62: INOR Orthopaedics Pipeline Products and Ongoing Clinical Trials Overview 46
Table 63: INOR TOTAL HIP SYSTEM Chromium Cobalt XL Series-LONG NECK - Product Status 46
Table 64: INOR TOTAL HIP SYSTEM Chromium Cobalt XL Series-LONG NECK - Product Description 46
Table 65: INOR TOTAL HIP SYSTEM Stainless Steel XL Series-Long Neck - Product Status 47
Table 66: INOR TOTAL HIP SYSTEM Stainless Steel XL Series-Long Neck - Product Description 47
Table 67: JRI Orthopaedics Ltd Pipeline Products and Ongoing Clinical Trials Overview 48
Table 68: Customised Hip Replacement Component - Product Status 48
Table 69: Customised Hip Replacement Component - Product Description 48
Table 70: KYOCERA Medical Corporation Pipeline Products and Ongoing Clinical Trials Overview 49
Table 71: Aquala Liner - Product Status 50
Table 72: Aquala Liner - Product Description 50
Table 73: Limacorporate S.p.a. Pipeline Products and Ongoing Clinical Trials Overview 51
Table 74: DELTA-ONE-TT - Product Status 52
Table 75: DELTA-ONE-TT - Product Description 52
Table 76: DELTA-Revision TT - Product Status 53
Table 77: DELTA-Revision TT - Product Description 53
Table 78: MX Orthopedics, Corp. Pipeline Products and Ongoing Clinical Trials Overview 54
Table 79: Shape Memory Alloy Hip Implant - Product Status 54
Table 80: Shape Memory Alloy Hip Implant - Product Description 54
Table 81: Nano Interface Technology, Inc. Pipeline Products and Ongoing Clinical Trials Overview 55
Table 82: Hip Implant - Product Status 55
Table 83: Hip Implant - Product Description 55
Table 84: Naviswiss AG Pipeline Products and Ongoing Clinical Trials Overview 56
Table 85: 6D Hip Surgery Measurement Device - Product Status 56
Table 86: 6D Hip Surgery Measurement Device - Product Description 56
Table 87: OrthoGrid Systems Pipeline Products and Ongoing Clinical Trials Overview 57
Table 88: HipFXGrid - Product Status 57
Table 89: HipFXGrid - Product Description 57
Table 90: OrthoPediatrics Corp. Pipeline Products and Ongoing Clinical Trials Overview 58
Table 91: Small Stature Hip - Product Status 58
Table 92: Small Stature Hip - Product Description 58
Table 93: PLD Corporation Limited (Inactive) Pipeline Products and Ongoing Clinical Trials Overview 59
Table 94: M-COR Primary Press-Fit - Product Status 59
Table 95: M-COR Primary Press-Fit - Product Description 59
Table 96: PreSRV Ltd. Pipeline Products and Ongoing Clinical Trials Overview 60
Table 97: Atlas Femoral Head Preserving Prosthesis - Product Status 60
Table 98: Atlas Femoral Head Preserving Prosthesis - Product Description 60
Table 99: Renova Orthopedics, LLC Pipeline Products and Ongoing Clinical Trials Overview 61
Table 100: A-FX Hip Fracture System - Product Status 61
Table 101: A-FX Hip Fracture System - Product Description 61
Table 102: SAS HyPrevention Pipeline Products and Ongoing Clinical Trials Overview 62
Table 103: H.I.P. CONCEPT - Product Status 62
Table 104: H.I.P. CONCEPT - Product Description 62
Table 105: SINTEF Pipeline Products and Ongoing Clinical Trials Overview 63
Table 106: Smart Hip Prosthesis - Product Status 63
Table 107: Smart Hip Prosthesis - Product Description 63
Table 108: Stryker Corporation Pipeline Products and Ongoing Clinical Trials Overview 64
Table 109: MITCH TRH System - Product Status 65
Table 110: MITCH TRH System - Product Description 65
Table 111: Tech Manage Corp. Pipeline Products and Ongoing Clinical Trials Overview 66
Table 112: Total Hip Prosthesis - Product Status 66
Table 113: Total Hip Prosthesis - Product Description 66
Table 114: University of Alberta Pipeline Products and Ongoing Clinical Trials Overview 67
Table 115: Hip Replacement And Bone Loss Monitor - Product Status 67
Table 116: Hip Replacement And Bone Loss Monitor - Product Description 67
Table 117: University of South Florida Pipeline Products and Ongoing Clinical Trials Overview 68
Table 118: Cannulated Screw Jig - Product Status 68
Table 119: Cannulated Screw Jig - Product Description 68
Table 120: Injectable Hip Hemiarthroplasty Device - Product Status 69
Table 121: Injectable Hip Hemiarthroplasty Device - Product Description 69
Table 122: University of Warwick Pipeline Products and Ongoing Clinical Trials Overview 70
Table 123: Femoral Head Positioning Device - Product Status 71
Table 124: Femoral Head Positioning Device - Product Description 71
Table 125: Zimmer Biomet Holdings, Inc. Pipeline Products and Ongoing Clinical Trials Overview 72
Table 126: Durom Full Resurfacing Hip - Product Status 73
Table 127: Durom Full Resurfacing Hip - Product Description 73
Table 128: E1 Avantage Hip Cup - Product Status 74
Table 129: E1 Avantage Hip Cup - Product Description 74
Table 130: ReCap Total Hip Resurfacing System - Product Status 75
Table 131: ReCap Total Hip Resurfacing System - Product Description 75
Table 132: Zimmer Biomet Holdings, Inc. - Ongoing Clinical Trials Overview 76
Table 133: ReCap Total Hip Resurfacing System - A Multicentre Prospective Randomised Control Trial to Compare Two Articulating Bearing Surfaces, Ceramic on Metal and Metal on Metal Large Diameter Femoral Heads, as Used in Cementless Primary Hip Arthroplasty 77
Table 134: ReCap Total Hip Resurfacing System - A Prospective Clinical Study on a Total Hip Resurfacing System 77
Table 135: ReCap Total Hip Resurfacing System - A Prospective Clinical Study On A Total Hip Resurfacing System 77
Table 136: ReCap Total Hip Resurfacing System - A Prospective, Multicentre Study Evaluating the Clinical Performance of the ReCap/Magnum in Total Hip Replacement and Resurfacing 78
Table 137: E1 Avantage Hip Cup - Evaluation of Cemented and Cementless Fixation of Dual-mobility Hip Prosthesis in Elderly Patients With Osteoarthritis 79
Table 138: E1 Avantage Hip Cup - RCT of the Sirius Stem Used in Conjunction with the Exceed ABT Cemented Cup and OptiPac/OptiVac Cement - Model Based RSA, Clinical and Radiographic Outcomes 79
Table 139: Glossary 154

1.2 List of Figures
Figure 1: Hip Reconstruction - Pipeline Products by Stage of Development 10
Figure 2: Hip Reconstruction - Pipeline Products by Segment 11
Figure 3: Hip Reconstruction - Pipeline Products by Territory 12
Figure 4: Hip Reconstruction - Pipeline Products by Regulatory Path 13
Figure 5: Hip Reconstruction - Pipeline Products by Estimated Approval Date 14
Figure 6: Hip Reconstruction - Ongoing Clinical Trials 15

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.